EHRA Premium Access

Current recommendation for atrial fibrillation patients undergoing ablation.

Presentation

About the speaker

Professor Jan Steffel

Hirslanden Heart Center, Zurich (Switzerland)
52 presentations
6 followers

4 more presentations in this session

Welcome and Introduction - Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Thumbnail

ELIMINATE-AF trial in the context of other non-vitamin K antagonist oral anticoagulant trials.

Speaker: Professor J. Kautzner (Prague, CZ)

Thumbnail

Implications of non-vitamin K antagonist oral anticoagulant trials in ablation practice.

Speaker: Doctor M. Grimaldi (Acquaviva Delle Fonti, IT)

Thumbnail

Panel discussion and closing remarks - Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Thumbnail

Access the full session

Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

Speakers: Professor J. Steffel, Professor S. Hohnloser, Professor J. Kautzner, Doctor M. Grimaldi, Professor S. Hohnloser
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk